Alucinaciones secundarias a tratamiento en paciente con Parkinson
نویسندگان
چکیده
La enfermedad de Parkinson (EP) se puede considerar como la segunda neurodegenerativa en cuanto a prevalencia refiere. EP es una carácter crónico que evoluciona fases consecutivas, con un diagnóstico inicial insidioso y manejo complejo para el médico Atención Primaria. En este artículo presentamos caso interacción medicamentosa poco estudiada entre fármacos antidepresivos antiparkinsonianos. paciente acudió revisión neurología y, ajuste medicación realizado por compañero neurología, añadió rasalagina su tratamiento habitual (levodopa/carbidopa) ello creó cuadro alucinaciones. Tras estudio pormenorizado del caso, llegó conclusión debía ser retirada neurológico alucinaciones remitió. Palabras clave: alucinaciones, interacciones medicamentosas, depresión, Parkinson.
منابع مشابه
Paniculitis en paciente con dermatomiositis
Panniculitis is a rarely reported clinical finding in dermatomyositis. It may precede the other manifestations associated with dermatomyositis by as much as 14 months. In all cases, myositis and panniculitis improve simultaneously during treatment. The present report describes the case of a 30-year-old female patient with clinical and histopathological findings consistent with panniculitis two ...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista Clínica de Medicina de Familia
سال: 2023
ISSN: ['1699-695X', '2386-8201']
DOI: https://doi.org/10.55783/rcmf.160110